市場調査レポート
商品コード
1226743
細胞増殖キットの世界市場:現状分析と予測(2022年~2028年)Cell Proliferation Kit Market: Current Analysis and Forecast (2022-2028) |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
細胞増殖キットの世界市場:現状分析と予測(2022年~2028年) |
出版日: 2023年01月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 142 Pages
納期: 即日から翌営業日
|
世界の細胞増殖キットの市場規模は、予測期間中に約7%のCAGRで成長すると予測されています。がんや腫瘍の患者数の増加、早期診断の増加、医療費負担を軽減するための政府の取り組みの増加、医療に対する意識の高まりは、市場の成長を促進しています。
当レポートでは、世界の細胞増殖キット市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。
The cell proliferation kit market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Cell replication, or the process of cell proliferation, is essential for maintaining the homeostasis of adult tissues by replacing dead cells with fresh ones. This process begins during embryogenesis. Abnormal cell proliferation is seen in a few disease conditions, such as cancer. So, in both in vitro and in vivo settings, cell proliferation assay kits gained popularity in the clinical diagnosis of various disease indications. These are used in research studies of cell activation, cytotoxicity assessment, and clinical trials to determine therapeutic efficacy. The growing demand for cell proliferation kits can be attributed to the rising numbers of patients with cancer and tumors across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for cell proliferation kits across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the cell proliferation kit market is anticipated to grow on account of the increasing number of early diagnostic procedures. In addition, the rise in government initiatives to control the healthcare burden and growing healthcare awareness among people drive market growth. However, some of the restraints in the market including the high cost of kits and lack of trained professionals are impeding the growth of this market all over the world.
Based on the type, the cell proliferation kit market is segmented into fluorometric cell viability kits, colorimetric cell viability kits, bioluminescent cell viability kits, and others. The colorimetric cell viability kits segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe. This method for detecting cell viability is cost-effective and easy to retrieve throughout data. It is also anticipated that the widespread use of this technique to identify various cellular activities, such as DNA synthesis, metabolic activity, and ATP production, will spur the expansion of the future market segment.
Based on the application, the market is fragmented into pharmaceutical and biotechnology companies, academic institutes and research laboratories, and others. The pharmaceutical and biotechnology companies segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Cell proliferation kits are used in academic institutions and research labs to identify cell damage by monitoring how the cells respond to various stimuli, such as hydrogen peroxide, antibiotics, etc.
For a better understanding of the market adoption of the cell proliferation kit, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the cell proliferation kit industry owing to the growing number of new cancer cases like melanoma, urothelial carcinoma, lung cancer, and others each year in the region. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region. For instance, according to the centers for Medicare & Medicaid services, U.S. healthcare spending grew 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 18.3%.
Some of the major players operating in the market include: Thermo Fisher Scientific Inc, Merck KGaA, GE Healthcare, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Becton Dickinson and Co, Biotium, Agilent Technologies Inc, F. Hoffmann-La Roche AG, and Biological Industries, among others. Several M&As along with partnerships have been undertaken.